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Abstract: Glutathione (GSH) and glutathione disulfide (GSSG) are commonly used to assess the
oxidative status of a biological system. Various protocols are available for the analysis of GSH and
GSSG in biomedical specimens. In this study, we present an optimized protocol for the in situ
derivatization of GSH with N-ethylmaleimide (NEM) to prevent GSH autooxidation, and thus to
preserve the GSH/GSSG ratio during sample preparation. The protocol comprises the incubation of
cells in NEM containing phosphate buffered saline (PBS), followed by metabolite extraction with 80%
methanol. Further, to preserve the use of QTOF-MS, which may lack the linear dynamic range required
for the simultaneous quantification of GSH and GSSG in non-targeted metabolomics, we combined
liquid chromatographic separation with the online monitoring of UV absorbance of GS-NEM at
210 nm and the detection of GSSG and its corresponding stable isotope-labeled internal standard by
QTOF-MS operated with a 10 Da Q1 window. The limit of detection (LOD) for GS-NEM was 7.81 µM
and the linear range extended from 15.63 µM to 1000 µM with a squared correlation coefficient R2 of
0.9997. The LOD for GSSG was 0.001 µM, and the lower limit of quantification (LLOQ) was 0.01 µM,
with the linear (R2 = 0.9994) range extending up to 10 µM. The method showed high repeatability
with intra-run and inter-run coefficients of variation of 3.48% and 2.51% for GS-NEM, and 3.11%
and 3.66% for GSSG, respectively. Mean recoveries of three different spike-in levels (low, medium,
high) of GSSG and GS-NEM were above 92%. Finally, the method was applied to the determination
of changes in the GSH/GSSG ratio either in response to oxidative stress in cells lacking one or both
monocarboxylate transporters MCT1 and MCT4, or in adaptation to the NADPH (nicotinamide
adenine dinucleotide phosphate) consuming production of D-2-hydroxyglutarate in cells carrying
mutations in the isocitrate dehydrogenase genes IDH1 and IDH2.
Keywords: glutathione; glutathione disulfide; cell culture; liquid chromatography; UV detection;
mass spectrometry
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1. Introduction
Glutathione is the major non-protein thiol in mammals, which is present at millimolar concentrations
within cells, especially in the liver [1]. In vivo, glutathione exists in a redox equilibrium between its
reduced monomeric (GSH) and oxidized dimeric form (GSSG). Glutathione, for the most part, does
not react directly with hydroperoxides, but is rather required in a two-step process to reduce the
oxidized selenocysteine residues of glutathione peroxidases that catalyze the reduction of hydrogen
peroxide and lipid hydroperoxides to water and their corresponding alcohols, respectively [2]. The two
molecules of GSH consumed in this process result in the formation GSSG, which is then reduced again
to GSH by NADPH in an enzymatic reaction catalyzed by glutathione reductase. The intracellular
content of GSSG is normally kept to less than 1% of total glutathione. The GSH/GSSG ratio is widely
used as an indicator of the redox state of cells or tissues, with marked decreases indicating oxidative
stress, i.e., a biological system’s failure to readily detoxify reactive oxygen species.
Over the years, several methods have been introduced for the determination of GSH and GSSG in
biospecimens, including spectrophotometric [3–5], UV [6], fluorometric [7–9], and mass spectrometric
techniques [10–13], either in batch or in combination with HPLC. In addition to improved detection
techniques, increasing attention has been paid to the effective prevention of GSH autooxidation during
sample collection and preparation when determining GSH and GSSG. As such, 2-Vinylpyridine (2-VP)
and N-ethylmaleimide (NEM) are two commonly used derivatizing agents for the analysis of GSH.
However, 2-VP suffers from poor cell membrane permeability and slow reactivity with GSH [3]. NEM,
on the other hand, is highly cell membrane-permeable and blocks the sulfhydryl group on the cysteinyl
residue of GSH quickly by alkylation, thereby stopping GSH autooxidation [14]. In addition, through
inhibition of glutathione disulfide reductase (GR), NEM also prevents the enzymatically catalyzed
reduction of GSSG [3,15]. Alternatively, an enzymatic recycling method has been reported for the
quantitative assay of GSH and GSSG. It involves the reaction of GSH with 5,5′-dithio-bis(2-nitrobenzoic
acid) (DTNB) to form UV detectable 5’-thio-2-nitrobenzoic acid (TNB) and the reduction of GSSG to
GSH by glutathione reductase and NADPH [4]. This method can be used to determine total glutathione
(GSH + GSSG). If the ratio of GSH and GSSG is of the interest, an additional sample aliquot is needed
where a -SH masking reagent, e.g., NEM, has to be added in advance. Thus, GSH amount can be
determined by subtracting GSSG from total glutathione. Giustarini et al. reported a protocol for
GSH and GSSG determination with NEM derivatization in blood and solid tissues [3] and cultured
cells [15]. This protocol allows the simultaneous determination of GSH and GSSG. However, GSSG was
determined by converting GSSG to GSH with dithiothreitol (DTT) reduction and subsequent fluorescent
labeling of the -SH group with monobromobimane (mBrB) for the detection. Moreover, excess NEM has
to be removed from the sample prior to DTT reduction and mBrB derivatization to avoid interferences
of NEM with the subsequent reduction and derivatization steps which makes the sample preparation
complicated and time-consuming. Recently, an LC-MS/MS method using NEM derivatization has
been developed and validated for the analysis of GSH and GSSG in porcine hepatocytes [16] and
the assessment of the thiol redox metabolome in blood, urine, and saliva, employing a Waters Xevo
TQ-S triple quadrupole mass spectrometer [17]. Tomin et al. [18] also reported an LC-MS/MS-based
protocol, employing an AB Sciex 4000 QTRAP® mass spectrometer, for the measurement of GSH and
GSSG in blood, tissue, and cultured cells in a single analysis. In that protocol, GSH was derivatized
with NEM, the reagent was removed and GSSG was reduced to GSH by TCEP (Tris (2-carboxyethyl)
phosphine) and then derivatized by d5-NEM (N-ethyl-d5-maleimide) to generate GSH-d5-NEM. Thus,
GSSG and GSH were detected as GSH-d5-NEM and GSH-NEM by LC-MS/MS with the addition
of 15C2,15N-GSH-d5-NEM as an internal standard. The sensitivity of GSSG detection was found to
be about 10-fold better than direct GSSG measurement and the samples were diluted before they
were subjected to LC-MS/MS analysis. However, the method requires elaborate sample preparation,
including two steps of NEM derivatization, protein precipitation, TCEP reduction, as well as the
removal of the excess NEM after the first derivatization step. For the analysis of a large number of
samples, a simpler and faster procedure is beneficial.
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Here, we report an optimized and simple method for the in-situ derivatization of GSH in cell
culture that involves the incubation of cells in PBS-buffered NEM before methanolic extraction of
GS-NEM, GSSG, and other metabolites of interest. In addition, we explored the coupling of liquid
chromatographic separation to on-line UV absorbance and selected ion monitoring on a QTOF-MS
instrument that may lack in contrast to a triple quadrupole mass spectrometer [16–18] the required
linear range for the simultaneous quantification of GSH as GS-NEM and GSSG, but allows for a
far more comprehensive analysis of the metabolome without having to set transitions for known
metabolites of interest. Finally, we tested the applicability of the method by demonstrating the impact
of genetic ablation of the monocarboxylate transporters MCT1 and MCT4 on the GSH/GSSG ratio of
colon cancer cells under oxidative stress as well as the effect that NADPH consuming neomorphic
mutations in the isocitrate dehydrogenases IDH1/2 have on the reduction of GSSG to GSH.
2. Results and Discussion
2.1. Chromatography and Mass Spectrometry
Figure 1A shows an extracted ion chromatogram of a GSSG standard measured by HPLC-ESI-
TOF-MS and the respective spectrum is given in Figure 1B. Figure 1C displays the UV chromatogram
of a GS-NEM standard. GSSG shows a quasi-molecular ion at m/z 613.160 and a doubly charged ion at
m/z 307.085. The latter yielded the higher intensity and was used for quantification. To improve the
sensitivity of GSSG determination by mass spectrometry, a 10 Da Q1 selection window was employed so
that only a limited m/z range covering unlabeled and stable isotope-labeled GSSG was transmitted and
detected. Compared to full scan detection, this led to a highly significant increase in the signal-to-noise
ratio of the GSSG peak (Supplementary Figure S1). GS-NEM yielded two separate peaks of equal
peak area ratio with an RSD of 3.13% at 6.7 min and 7.8 min due to the generation of diastereomers
that are separated under the given chromatographic conditions (Supplementary Figure S2). Here,
the peak eluting at 6.7 min was used for GS-NEM quantification. GS-NEM was also detected by
QTOF-MS. No other biomolecules existing in the samples coeluted with GS-NEM as evidenced by
Supplementary Figure S3 demonstrating that a pooled cell sample and a GS-NEM standard share
the same MS spectrum at 6.7 min. Intracellular GSH and GSSG amounts may differ by more than
three orders of magnitude. Thus, simultaneous MS analysis of both glutathione forms will require
an instrument with a linear range that covers four orders of magnitude, such as a triple quadrupole
instrument. However, with the QTOF instrument used in this study, the response for GS-NEM was
only linear up to a concentration of 62.5 µM. However, typical extract concentrations of GS-NEM were
around 200 µM. Even modification of the MS parameters used for GS-NEM detection did not extend
the linear range sufficiently (Supplementary Figure S4). Hence, GSSG and GSH would have to be
determined separately after appropriate dilution of the sample. Thus, here, MS detection was only
used to monitor the potential influences arising from the complex cell samples and UV absorbance
was employed to quantify GS-NEM.
2.2. Method Validation
For GSSG determination, the limits of detection and quantification were 0.001 µM and 0.0098 µM,
respectively. Compared to previously published methods as shown in Table 1, the here presented method
features better detection sensitivity for GSSG. A twelve-point calibration covering a concentration
range of 0.0098 µM to 10 µM yielded excellent linearity (R2 = 0.9994). For GS-NEM determination,
a nine-point calibration curve was generated, the linear range of which extended from 15.63 µM to
1000 µM (R2 = 0.9997). The LOD for GS-NEM was 7.81 µM. Representative calibration curves for both
GSSG and GS-NEM are shown in Figure 2.
Metabolites 2020, 10, 292 4 of 15
Metabolites 2020, 10, x FOR PEER REVIEW 4 of 16 
 
 
Figure 1. Chromatographic separation and detection of GSSG and GS-NEM. (A) Extracted ion 
chromatogram (XIC) and (B) mass spectrum of GSSG standard measured by HPLC-ESI-QTO-FMS. 
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of GSSG at m/z 307 in Figure 1B was used for GSSG determination throughout the study. In Figure 
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Table 1. Comparison of methods reported for the determination of GSH and GSSG.
Method Sample GSHLOD *
GSH
LOQ *
GSSG
LOD *
GSSG
LOQ * Derivatization Ref.
Enzymatic recycling Rat liver/bil – 6.25 pmol – 2.17 mol M4VP [19]
HPLC-UV Erythrocytes 820 pmol(0.041 mM)
2700 pmol
(0.135 mM) – – DTNB [20]
HPLC-fluorescence Plasma 0.6 pmol(0.03 µM)
2 pmol
(0.10 µM) – – NBD-F [8]
LC-MS/MS Whole blood 4 pmol(0.4 µM)
15 pmol
(1.5 µM)
1.5 pmol
(0.1 µM)
1.5 pmol
(0.1 µM) NEM [13]
HPLC-UV Cultured cells – – – – NEM/DTT/mBrB [15]
HPLC-UV
Cultured cells
78.1 pmol
(7.81 µM)
156.5 pmol
(15.65 µM) – – NEM This study
HPLC-QTOF-MS – – 0.01 pmol 0.1 pmol –
M4VP: 1-methyl-4-vinyl-pyridinium; DTNB: 5,5′ -dithio-bis-(2-nitrobenzoic acid); NBD-F: 7-flouro-4-nitrobenzo-
2-oxa-1,3-diazole; NEM: N-ethylmaleimide; mBrB: monobromobimane; DTT: dithiothreitol. * Amount of substance
loaded on column. LODs and LOQs presented in each study were converted to the same unit and shown as amount
of substance loaded on column by multiplying the concentration of the analyte with the injection volume in each
study. The concentrations shown in the brackets are the original values presented in each study.
It should be noted that high amounts of GSSG were observed in GSH standard stock solutions
after storage for one month at –20 ◦C (data not shown). To generate a reliable GS-NEM calibration
curve, GSH stock solutions should be either freshly prepared from powder or the concentration must
be recalculated through the quantification of GSSG in the stock solution.
Within-run precision was evaluated by ten successive injections of a pooled cell culture sample.
The obtained peak areas of GS-NEM and the peak area ratios of GSSG to GSSG internal standard are
shown in Supplementary Figure S5. The corresponding coefficients of variation (CV) for within-run
repeatability of GS-NEM and GSSG were 3.48% and 3.11%, respectively. Inter-run repeatability was
determined by injecting aliquots of the same pooled cell culture sample on five successive days in
triplicate each day (see Supplementary Figure S6). A CV of 2.51% and 3.66% was obtained for GS-NEM
and GSSG, respectively.
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Quality control samples (QCs) of GSSG and GS-NEM were prepared from stock solutions prior to
the analysis on five different days over a period of five months (see Figure 3). All QC samples showed an
accuracy in the range of 80–120%. For GSSG, the respective accuracies were 96.74 ± 4.54% (calcheck1),
96.16 ± 5.16% (calcheck2), 99.27 ± 5.34% (calcheck3), 102.46 ± 6.60% (calcheck4), and 106.47 ± 16.00%
(calcheck5). The corresponding accuracies for GS-NEM were 101.20 ± 3.40% (calcheck1), 104.29 ± 5.40%
(calcheck2), 107.46 ± 6.68% (calcheck3), 105.32 ± 6.58% (calcheck4), and 103.79 ± 19.83% (calcheck5).
Calch ck5, the cl sest to the LLOQ, featured the highest standard deviations of 16.00% and 19.83%,
respectively, for GSSG and GS-NEM. However, mean a curacies of 106.47% and 103.79% for GSSG and
GS-NEM, respectivel , w re still acceptable.
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Figure 3. Accuracies of five quality control sa l s easured on different days. QCs were standard
sample prepared f om different s ock solutio 3) on different days (n = 5) within five months.
(A) The concentrations of calcheck1 to calcheck5 for SSG were 3 µM, 1.5 µ , 0.15 µM, 0.05 µM,
and 0.02 µM, respectively. (B) The corresponding concentrations for calcheck1 to calcheck5 for GS-NEM
were 500 µM, 200 µM, 100 µM, 50 µM, and 20 µM.
Furthermore, we investigated the stability of GS-NEM solutions under different storage conditions.
A standard GS-NEM sample was stored at 4 ◦C, −20 ◦C, and −80 ◦C, respectively, for the periods of
time indicated in Figure A. The CVs of average peak area over all injections (15 injections in total)
were 3.10% (4 ◦C), 5.66% (−20 ◦C), and 2.47% (−80 ◦C), respectively, thus attesting to adequate sample
stability over at least one month.
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(B) Total GSH was me sured after DTT r uction in a separate set of samples and both tGSH and
GS-NEM were normalized to protein amount. No significant difference was observed between GS-NEM
and tGSH (p = 0.53, n = 3).
2.3. Cell Harvesting
The timing of the addition of NEM to cultured cells is critical for the accurate determination of GSH
as is evident from Supplementary Figure S7. The amount of GSSG determined decreased dramatically
by adding NEM already during cell harvesting instead of adding it later to the methanolic cell extract.
This impressively shows the importance of immediately trapping GSH to prevent autooxidation when
analyzing GSSG in cultured cells.
To further optimize the protocol, we tested four different cell harvesting procedures:
Procedure 1: As described above, the cell culture medium was removed, and the cells were washed
twice for 1 min with PBS containing 1 mM NEM prior to cell harvesting in cold 80% methanol.
Procedure 2: Cells were washed twice with 1 mL of PBS prior to addition of 400 µL of 1 mM NEM
solution for 5 min, followed by addition of 1600 µL methanol (to a final concentration of 80%, v/v) to
harvest cells in cold 80% methanol.
Procedure 3: Cells were washed twice with 1 mL of PBS and then scrap ed with 1 mL of cold 80%
methanol co taini g 0.5 mM NE .
Procedure 4: NEM was ad ed directly to the cell culture medium at a final concentration of ~1.5 mM
for 2 min. Then, culture medium was di carded, cells were washed with PBS and scraped in 80%
cold methanol.
Cells were se ded at the same density and each procedure was performed in triplicate. Results
are shown in Sup lementary Figure S8. No significant difference betwe n the four procedures was
observed for GS-NEM (ANOVA p = 0.59). However, a significant lower GS G amount was detected
when cells were washed with PBS containing 1 mM NEM (procedure 1), indicating that auto xidation
was kept to a minimum. In procedure 4, NEM was ad ed directly to the cell culture medium prior to
PBS washing. Components present in the medium may compete for or int rfere with th d rivatization
of GSH with NEM, which may be over o e by higher concentrations of NEM, and influence the
reactio efficiency. Consequ tly, proc d re 1 becam the standard protocol. Besides, no free GSH
was det cted in cell culture samples after NEM derivatization (data not shown), indicating sufficient
derivatization of GSH with NEM. Of note, the reaction rate of GSH with NEM in m thanol is fairly low
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compared to the reaction in aqueous solution. Using standard samples, we observed that more than
40 min of incubation were necessary when the reaction was performed in 80% methanol. In contrast,
the reaction is complete within minutes in aqueous solution.
Using the colorectal adenocarcinoma cell line LS174T, we also compared the quantification of
GSH as GS-NEM with the determination of total reduced GSH (tGSH) in a separate set of samples
to validate the GS-NEM method. Quantification of tGSH employing DTT reduction was performed
according to our previously reported method [21]. Briefly, cell extracts were generated using 80%
methanol extraction, followed by DTT reduction to obtain total glutathione in reduced form and the
analysis of tGSH by HPLC-QTOF-MS/MS. The results are shown in Figure 4B. There is no significant
difference between GS-NEM and tGSH amount after normalization to protein amount. This indicates
correct analysis of GSH by HPLC-UV after NEM derivatization, as the very low intracellular amounts
of GSSG will not contribute significantly to tGSH.
Furthermore, spike-in experiments were performed with LS174T wild type cells to assess GSH
(GS-NEM) and GSSG recovery. To minimize autooxidation artefacts, GS-NEM rather than GSH was
used for the spike-in experiments. Three different GS-NEM or GSSG standard solutions of known
concentration (low, medium, and high) were added to the culture dishes and cell extraction was
performed as described above. The spike-in amounts were selected according to the endogenous
levels of GSH (GS-NEM) and GSSG measured previously in LS174T wild type cells, which were about
20 nmol absolute for GSH and 0.02 nmol absolute for GSSG. Based on the endogenous levels, spike-in
amounts of 10, 20, and 40 nmol for GS-NEM, and 0.02, 0.06, and 0.2 nmol for GSSG were selected.
For each experiment, three replicates were generated. As shown in Figure 5, recovery of GS-NEM and
GSSG was satisfactory for all three spike levels. Mean recovery of GS-NEM ranged between 92.2%
and 101% (101.01 ± 7.96%, 94.25 ± 2.00%, and 92.15 ± 1.06%) while the mean recovery and standard
deviation for GSSG was 104.28 ± 11.18%, 98.70 ± 1.99%, and 97.49 ± 9.60%, respectively.
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Figure 5. (A) GS-NE and (B) GSSG spike-in experiments. Recovery was determined by adding
defined amounts of GS-NEM or GSSG at low (10 nmol of GS-NEM, 0.02 nmol of GSSG), medium (20 nmol
of GS-NEM, 0.06 nmol of GSSG), and high (40 nmol of GS-NEM, 0.2 nmol of GSSG) concentration
into LS174T wild type cell cultures before 80% methanol cell extraction. GS-NEM and GSSG recovery
experiments were performed separately (n = 3 for each).
2.4. GSH and GSSG Determination in Monocarboxylate Transporter Deficient Cells
To demonstrate the applicability of the developed HPLC-UV-QTOF-MS method, we measured
the intracellular concentrations of GSH and GSSG in parental LS174T cells as well as derived single
(SKO) and double knockout (DKO) clones of the monocarboxylate transporters MCT1 and MCT4. As is
evident from Figure 6A, under normal cell culture conditions both parental and SKO cells exhibited
similar GSH/GSSG ratios with a more than 2000-fold molar excess of GSH, while the GSH/GSSG ratio of
the DKO cells was significantly lower but still in excess of 1500:1. This can be readily explained by the
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observation [22], that complete disruption of MCT activity in LS174T cells by a combination of genetic
and pharmacological means results in a more than six-fold increase in oxidative phosphorylation,
which leads in turn to the increased generation of mitochondrial reactive oxygen species (ROS) and,
consequently, an increase in cellular content of GSSG. As expected, when cells were challenged with
0.2 mM H2O2 for 10 min, all four cell lines showed a dramatic decrease in the GSH/GSSG ratio compared
to the corresponding unstressed condition due to a collapsing NADP+/NADPH ratio (p < 0.001 for
all cell lines, normal condition versus H2O2 treatment) (Figure 6B). However, rather unexpectedly,
the decrease in GSH/GSSG ratio upon H2O2 treatment was by far the most pronounced in the MCT4−/−
SKO cells (for statistics see Supplementary Table S1).
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n.s., not significant, for furthe ta istics see Suppl mentary Table S1. Detailed data presented in this
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Any attempt to interpret the above finding needs to account for the fact that both, differences
in the expression of MCT1 and MCT4 as well as the choice of methodology to knock them out or
down or to inhibit them pharmacologically may exert different effects on cell metabolism. In cells that
express little, if any, MCT4, knockdown or pharmacological inhibition of MCT1 has been reported
to result, amongst others, in increased levels of glucose- and fructose-6-phosphate, as was observed
here, as well as in marked reductions in the intracellular levels of pyruvate and GSH and in reduced
glucose uptake and lactate efflux, all of which were not detected in the present study [23]. In contrast,
knockdown or pharmacological inhibition of MCT1 in cells expressing considerable amounts of MCT4
resulted in reduced pyruvate export and increased oxygen consumption, accompanied by increased
expression of genes involved in oxidative phosphorylation, while the expression of glycolytic genes
such as hexokinase 1, phosphofructokinase M, and enolase 1 was decreased. Moreover, continued
glucose uptake and lactate export were sustained by MCT4 [24]. Increased mitochondrial respiration
and the consequently enhanced generation of ROS are known to inactivate the M2 isozyme of pyruvate
kinase (PKM2) through oxidation of Cys358 [25]. The resulting accumulation of phosphoenolpyruvate,
in turn, results in direct catalytic inhibition of triosephosphate isomerase. This mediates a protective
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diversion of glucose flux into the oxidative branch of the pentose phosphate pathway (PPP) to generate
NADPH required for the reduction of the antioxidants glutathione, thioredoxin and peroxiredoxin [26].
MCT1 facilitates the proton-linked bi-directional transport of both lactate and pyruvate, while MCT4
is considered primarily a high-affinity exporter of lactate with a significantly lower affinity for
pyruvate [27]. Indeed, under unstressed conditions, growth rate adjusted export of pyruvate was lower
in MCT1−/− than MCT4−/− SKO cells, while they did not differ in glucose uptake and lactate release
from the parental clone (Supplementary Figure S9A–C). Given that LS174T cells express only MCT1
and MCT4 [22], genetic ablation of both MCT1 and MCT4 resulted in an almost complete inhibition of
pyruvate and lactate export and very little glucose uptake, as DKO cells meet their energy requirements
mostly by oxidative phosphorylation [22]. The present observation, that both the MCT1−/− SKO and
the MCT1−/−/MCT4−/− DKO clone exhibit a higher abundance of glucose and glucose 6-phosphate
(Supplementary Figure S9D) than the MCT4−/− SKO clone under unstressed conditions, may provide
an important clue toward understanding the pronounced drop of GSH/GSSG ratio in the MCT4−/−
SKO clone upon H2O2 treatment (Supplementary Figure S9B). As shown previously, MCT1 blockade
leads to increased mitochondrial respiration and generation of ROS, which redirect via inhibition of
triosephosphate isomerase glucose flux to the PPP [22,24]. MCT4−/− null cells, in contrast, show under
unstressed conditions neither a significant increase in extracellular acidification rate (ECAR) nor a
significant decrease in intracellular pH [22]. The roughly two-fold increase in oxygen consumption
rate (OCR) is also very modest. As cells experience an oxidative burst upon exposure to H2O2, they
inactivate glycolysis within seconds via oxidation of not only pyruvate kinase but also glyceraldehyde
3-phosphate dehydrogenase, while glucose flux through the PPP continues to generate NADPH [28].
Given that glucose flux through the PPP is already increased in MCT1 deficient cells, these cells can
stage most likely a faster response to H2O2 exposure, which should be reflected in lower intracellular
GSSG levels compared to MCT4−/− SKO cells and MCT1−/−/MCT4−/− DKO cells. Indeed, as evident from
Supplementary Figure S10B and D, intracellular levels of GSSG in MCT1−/− SKO cells are similar to
those found in wild type cells under both unstressed and stressed conditions, with only the level of GSH
being somewhat lower in MCT1−/− SKO cells under oxidative stress (Supplementary Figure S10A,C).
Both MCT4−/− SKO and MCT1−/−/MCT4−/− DKO cells show highly significant increases in GSSG content
compared to parental and MCT1−/− SKO cells under stressed condition (Supplementary Figure S10D).
Interestingly, the increase in GSSG content in DKO cells as compared to MCT competent cells is lower
than in MCT4−/− SKO cells (Supplementary Figure S10D) and further compensated by a higher GSH
content in the DKO cells (Supplementary Figure S10C). In conclusion, it appears that MCT4−/− null
cells are poorly adapted to sudden bursts of oxidative stress.
2.5. GSH and GSSG Determination in Isocitrate Dehydrogenase Wild Type and Mutant Cells
Next, we applied the developed method to the determination of the intracellular levels of GSH
and GSSG in the colon cancer cell line HCT116, in which we had already determined previously
total GSH content [21]. The wild type and isocitrate dehydrogenase 1/2 (IDH1/2) mutant cell clones
IDH1-R132H, IDH2-R172K, and IDH2-R140Q, respectively, were used to study the effect on the
GSH/GSSG ratio in cells carrying neomorphic IDH1/2 mutations, which enable cells to catalyze the
NADPH consuming reduction of α-ketoglutarate (α-KG) to D-2-hydroxyglutarate (D-2-HG) (see
Figure 7A) [29–31]. As shown in Figure 7B, all mutIDH cell lines show a significant lower GSH/GSSG
ratio compared to the wild type cell line (for statistics, see Supplementary Table S3), supporting the
notion that increased consumption of NADPH by IDH1/2 mutant cells will impair their ability to reduce
GSSG to GSH. Interestingly, the GSH/GSSG ratios observed in the three mutant cell lines appear to
correlate indirectly with the amounts of D-2-hydroxyglutarate detected in these cells [32]. Furthermore,
mutIDH1 cells seem to be less capable of regenerating GSH than mutIDH2 (mitochondrial isoform)
cells. IDH1 is the cytosolic isoform, and therefore increased consumption of NADPH by the mutated
enzyme has a more direct effect on the reduction of GSSG, which also takes place in the cytosol.
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Figure 7. (A) Scheme depicting the reactions catalyzed by wild type and mutant IDH enzymes and
their respective effects on the provision of NADPH for the reduction of GSSG to GSH by glutathione
reductase. (B) Effect of different IDH1/2 mutations on the GSH/GSSG ratio in HCT116 cells compared to
IDH1/2 wild type cells. * p < 0.05, ** p < 0.01, *** p < 0.001, n = 3, for further statistics see Supplementary
Table S5.
3. Experimental
3.1. Chemicals and Reagents
Stable isotope-labeled glutathione disulfide (glutathione-(glycine-13C4,15N2)) was acquired from
Toronto Research Chemicals (Toronto, Canada). GSH, GSSG, and NEM were purchased from Sigma
Aldrich (Taufkirchen, Germany). Solvents for sample preparation and HPLC-MS analysis were HPLC
grade and obtained from Th. Geyer GmbH (Renningen, Germany).
3.2. Stock Solutions
Stock solutions of unlabeled GSH (2 mM) and GSSG (1 m ), and stable isotope-labeled GSSG
(10 mM) were prepared in purified water (PURELAB Plus syste , EL Lab ater, Celle, Germany)
and stored at –20 ◦C. Working s l ti s ere prepared freshly before analysis. Aliquots of NEM
(310 mM) were prepared in purified water and stored at –20 ◦C. In-house quality controls (QCs) o five
different conce tra ion lev ls of GS-NEM (50 µM, 200 µ , 1 , 20 µ ) and G SG
(3 µM, 1.5 µM, 0.15 µM, 0.05 µM, and 0.02 µM) wer also prepared freshly.
3.3. Cell Cult re and Sample Prepar tion
LS174T wild type and MCT1/4 single and double knocko t cl e l as CT 16 wild
type and IDH mutant cell ( rizon Discovery Ltd., Cambridge, UK) were cultivated in RPMI
(PAN, Aidenbach, Germany), supplemented with 10% FCS (Biochrom A , Berlin, Germany), 1%
penicillin-streptomycin (PAA Laboratories Inc., Pasching, Austria), and 2 M L-glutamine (PAA).
Cells were seeded in 6-well plates in triplicates at a density of 450,000 cells per well and incubated
overnight at 37 ◦C, 5% CO2.
To harvest cells for GSSG and GSH analysis, the medium was discarded, and the cells were
washed twice for 1 min each with 1 mL PBS (PAN) containing 1 mM NEM. Then, 10 µL of 25 µM GSSG
internal standard were added to each well before cells were scrapped in 600 µL of cold 80% methanol.
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The extract was transferred to a 1.5 mL cup and the wells were washed with 400 µL cold 80% methanol.
The wash was collected into the same cup. Samples were then stored overnight at −80 ◦C.
The collected cell extracts were centrifuged at 4 ◦C and 10,000× g for 5 min. The supernatants were
collected, and the pellets were washed twice with 200 µL 80% methanol. The combined supernatants
were evaporated to dryness (CombiDancer, Hettich AG, Bach, Switzerland) and then re-dissolved in
50 µL pure water before HPLC-UV-QTOF-MS analysis.
3.4. HPLC-UV-QTOFMS Analysis of GSH and GSSG
Instrumental analysis was carried out on a Maxis Impact QTOF-MS (Bruker Daltonics, Bremen,
Germany) with an ESI source coupled to a Dionex Ultimate 3000 UHPLC system (Thermo Scientific, Idstein,
Germany) consisting of a HPG3400 RS pump, WPS3000TFC autosampler, and a Dionex diode-array
detector. Chromatographic separation was performed on a Waters Atlantis T3 reversed-phase column
(2.1 × 150 mm, 3 µm) fitted with a 2.0 × 4 mm C18 pre-column (Phenomenex, Aschaffenburg, Germany).
Mobile phases A and B were 0.1% (v/v) formic acid in H2O and acetonitrile, respectively. Gradient
elution was started with a 15 min isocratic segment at 95% A, before ramping B from 5% to 100% in
2 min, followed by a 3 min hold and re-equilibration at 95% A for 5 min. The column temperature was
set at 35 ◦C and a flow rate of 0.3 mL/min was used. Samples were injected in random order with an
injection volume of 10 µL.
For GS-NEM determination, the diode-array detector was operated over a range of 200 to 400 nm.
The GS-NEM absorption peak was extracted at 210 nm. The eluent from the diode-array detector was
subsequently transferred to the QTOF mass spectrometer via an ESI source for GSSG detection in
positive mode using either full scan 50 to 1000 m/z or a 10 Da Q1 selection window. GSSG quantification
was achieved using a 12-point calibration curve based on the area ratios of unlabeled to stable
isotope-labeled compound. GS-NEM quantification was performed using a calibration curve generated
from the HPLC-UV measurements of a serial dilution of a GS-NEM standard solution. MS parameters
and mass calibration were as recently reported [21]. For internal recalibration, each run was started
with injection of a sodium formate solution [21] by a six-port valve. Mass spectrometry detection
was divided into different segments for the separate monitoring of sodium formate clusters, GSSG,
and GS-NEM.
Determination of lactate, pyruvate, glucose, and glucose-6-phosphate was performed as described
in Supplementary File S1.
3.5. Method Validation
3.5.1. Figures of Merit
The linear range for GSSG quantification was determined based on a serial dilution of a GSSG
standard (10 µM to 0.0024 µM) with a constant concentration of the internal standard (5 µM).
The calibration curve was built based on the peak area ratio of analyte to internal standard versus the
corresponding nominal concentration ratio. The lower limit of quantification (LLOQ) and limit of
detection (LOD) were defined according to the FDA Guide for Bioanalytical Method Validation [33]
with LLOQ as the lowest calibration curve concentration, for which the analyte can be quantitatively
determined with an accuracy of 80–120%, and the LOD as the lowest analyte concentration that yields
a peak with S/N ≥ 3.
Linearity of GS-NEM quantification was evaluated in a concentration range of 15.63 µM to
1000 µM. A GS-NEM standard solution was produced by the reaction of fresh GSH standard with
NEM in the lab. Calibration samples were diluted from a standard GS-NEM solution.
3.5.2. Stability of GS-NEM
Stability of GS-NEM derivative was assessed by comparing peak areas obtained for a 200 µM
GS-NEM standard solution stored at 4 ◦C, −20 ◦C, and −80 ◦C for different time periods.
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3.5.3. Recovery
Recovery of GS-NEM and GSSG was assessed separately by spiking low, medium, and high
amounts of GS-NEM (10 nmol, 20 nmol, concentration in the stock solution was recalculated by the
quantification of GSSG with the 40 nmol) or GSSG (0.02 nmol, 0.06 nmol, 0.2 nmol) into cell cultures
prior to sample preparation. Recovery of GS-NEM and GSSG was determined separately to avoid the
interference of GSSG present in GSH standard solution due to auto-oxidation. GSH addition of stable
isotope labeled GSSG internal standard. Furthermore, blank samples, cell samples without addition of
GS-NEM or GSSG, were analyzed to determine endogenous GSH and GSSG amounts, which were
subtracted from the values determined in the spiked samples for recovery calculation. Using GSSG as
an example, recovery was determined as follows:
Recovery =
GSSG amount in spiked sample−GSSG amount in blank sample
theoretical amount o f GSSG standard spiked
× 100%
Absolute amounts were normalized to protein amount in each sample to correct for differences in
cell number. All experiments were performed in triplicate.
3.6. Data Analysis and Statistics
Data analysis was carried out using Bruker QuantAnalysis 2.2 software. Statistical differences
between more than 2 groups were tested using single factor ANOVA with Tukey’s post-hoc HSD test
in R version 3.5.1, while differences between two groups were tested by the unpaired two-tailed t-test
implemented in Excel 2013. A value of p < 0.05 was considered statistically significant. Results are
presented as mean plus standard deviation (M+SD). Figures were prepared with GraphPad Prism 6.
4. Conclusions
The analysis of GSH/GSSG ratio in cell culture is a challenging task due to auto-oxidation of
GSH during cell harvesting and metabolite extraction. Here, we have optimized both the in-situ
derivatization of GSH with NEM and the simultaneous determination of GSH and GSSG by HPLC-UV
and LC-QTOF-MS in cultured cells. The method is rapid and shows high sensitivity, excellent precision,
and nearly complete recovery of both GSH and GSSG in spike-in experiments.
Supplementary Materials: The following are available online at http://www.mdpi.com/2218-1989/10/7/292/s1,
Figure S1: Comparison of signal-to-noise ratio for 2.5 µM solution of GSSG measured by mass spectrometry in full
scan or MRM mode (n = 3). Figure S2: Peak area comparison of GS-NEM diastereomers analyzed by HPLC-UV.
Diastereomers eluted at 6.7 min and 7.8 min, respectively. Peak area ratios of the GS-NEM diastereomers in
cultured cell samples are all stably around 1 with an RSD of 3.13%. Figure S3: Exemplary MS spectra of GS-NEM
detected by QTOF-MS in (A) standard sample and (B) pooled cell sample. GS-NEM shows a [M+H]+ ion at
m/z 433 and a fragment ion at m/z 304 due to the loss of Glu. Figure S4: (A) Extracted ion chromatograms of
quasi-molecular ion (m/z 433.14) of GS-NEM (31.25 µM) detected by mass spectrometry with different parameter
settings. (B) Extracted ion chromatogram of quasi-molecular ion (m/z 433.14) of GS-NEM (250 µM) analyzed by
LC-QTOF-MS. Detection saturation of GS-NEM was still a problem with each setting. In our experiments, GS-NEM
concentrations detected in cell extracts were mostly higher than 200 µM. However, as shown in Figure S4B,
detection saturation is severe when a GS-NEM solution with a concentration of 250 µM was analyzed, indicating
the necessary dilution of the samples for MS detection. Figure S5: (A) Peak areas of GS-NEM and (B) peak area
ratios of GSSG to GSSG internal standard for ten successive injections of a pooled cell culture sample measured by
HPLC-UV-QTOF-MS. Figure S6: (A) Peak areas of GS-NEM and (B) peak area ratios of GSSG to GSSG internal
standard (GSSG is) for a pooled cell culture sample measured on 5 successive days by HPLC-UV-QTOFMS (n = 3
for each day). Figure S7: Peak area of GSSG detected in cell culture samples after derivatization of GSH with
NEM either in the final extract or during cell harvesting by adding NEM to the PBS wash (n = 3). Figure S8:
Optimization of the NEM derivatization procedure. Procedure 1, cell medium was discarded, followed by two
1-min washing steps with PBS containing 1 mM NEM. Procedure 2, cell medium was discarded, followed by
PBS washing twice. Then, 400 µL of 1 mM NEM was added to the cells and incubated at room temperature for
5 min before harvesting the cells in 80% methanol. Procedure 3, cells were harvested with 1 mL of 80% methanol
containing 0.5 mM NEM after PBS washing twice. Procedure 4, 10 µL of 310 mM NEM were added directly
to the cells and incubated for 2 min before discarding the medium and PBS washing, n = 3 for each procedure.
No significant difference in GS-NEM amount was observed between groups (ANOVA, p = 0.59). For GSSG,
significant differences were found between groups (ANOVA, p = 0.0068): 1 versus 2: p = 0.0364; 1 versus 3:
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p = 0.0171; 1 versus 4: p = 0.0064. One-way ANOVA and post hoc analysis with Tukey’s test were performed in R
(version 3.5.1). Figure S9: Release of (A) pyruvate and (B) lactate as well as uptake of glucose normalized to (C)
area under the growth curve, and (D) intracellular content of glucose and glucose 6-phosphate (G6P) in unstressed
LS174T parental and MCT1/4 single and double knockout clones cultured for 24 h. Metabolites in methanolic
extracts of both cell culture supernatants (A, B) and cell pellets (D) were analyzed by GC-MS. Two independent
experiments (n = 6, three for each experiment) were performed. (ANOVA for pyruvate p = 5.1 × 10−4, for lactate
secretion p = 9.7 × 10−9, for glucose uptake p = 1.3 × 10−9, for intracellular glucose p = 2.4 × 10−6 and intracellular
G6P p = 2.8×10−5, * p < 0.05, ** p < 0.01, *** p < 0.001, n.s., not significant). For further statistics see Table S2.
GC-MS analysis of lactate, pyruvate, glucose and glucose 6-phosphate, protein content determination, and cell
proliferation rate determination see above experimental section. Figure S10: Intracellular levels of GSH (A and
C) and GSSG (B and D) in LS174T parental and MCT1/4 single and double knockout clones before (unstressed,
n = 6 each) and after treatment with 0.2 mM H2O2 for 10 min (n = 3 each). One-way ANOVA (p = 0.0473 for GSH,
unstressed; p = 7.44 × 10−7 for GSSG, unstressed; p = 1.65 × 10−4 for GSH, H2O2 treated; p = 2.04 × 10−6 for GSH,
H2O2 treated) and post hoc analysis with Tukey’s test were performed in R (version 3.5.1). * p < 0.05, ** p < 0.01,
*** p < 0.001. Detailed data presented in this figure were summarized in Table S4. Table S1: Analysis of variance
(ANOVA) of GSH/GSSG ratio between MCT-competent and MCT-deficient LS174T cells under normal or H2O2
treatment conditions was performed in R (version 3.5.1). Pairwise comparisons between cell lines under each
condition were performed with Tukey’s post hoc test. A paired t-test (EXCEL 2013) was used to test the impact
of H2O2 treatment in each cell line. A p-value of less than 0.05 was statistically significant. n.s., not significant.
Table S2: Analysis of variance (ANOVA) of pyruvate secretion, lactate release, glucose uptake, and intracellular
glucose and G6P content between MCT-competent and MCT-deficient LS174T cells under normal conditions were
performed in R (version 3.5.1). Pairwise comparisons between cell lines under each condition were performed
with Tukey’s post hoc test. A p-value of less than 0.05 was statistically significant. n.s., not significant. Table S3:
Extract concentrations of GSH and GSSG from LS174T cells with/without H2O2 treatment. Data are shown in
Figure 6. Table S4: GSH and GSSG amounts in LS174T cells with/without H2O2 treatment after normalization
to total protein. Data are presented in Figure S9. Table S5: Analysis of variance (ANOVA) of GSH/GSSG ratios
between HCT116 cell lines was performed in R (version 3.5.1) with Tukey’s post hoc test. A p-value of less than
0.05 was considered statistically significant. n.s., not significant. Supplementary File S1.
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